USD 2.88
(7.46%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 411.67 Million BRL | N/A |
2022 | 594.51 Million BRL | -28.11% |
2021 | 853 Million BRL | 129.14% |
2020 | 165.21 Million BRL | 2770.67% |
2019 | -68.11 Million BRL | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q1 | 88.6 Million BRL | 956.7% |
2023 Q3 | 79.66 Million BRL | -72.02% |
2023 Q2 | 284.73 Million BRL | 221.37% |
2022 FY | - BRL | -28.11% |
2022 Q4 | -10.34 Million BRL | 91.89% |
2022 Q3 | -127.58 Million BRL | -126.96% |
2022 Q2 | 473.22 Million BRL | 68.34% |
2022 Q1 | 281.11 Million BRL | 363.54% |
2021 Q1 | 148.77 Million BRL | 345.57% |
2021 FY | - BRL | 129.14% |
2021 Q2 | 148.77 Million BRL | 0.0% |
2021 Q4 | -106.66 Million BRL | -149.95% |
2021 Q3 | 213.56 Million BRL | 43.55% |
2020 FY | - BRL | 2770.67% |
2020 Q4 | -60.58 Million BRL | 0.0% |
2019 FY | - BRL | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Bioceres Crop Solutions Corp. | 54.15 Million USD | -660.218% |
N2OFF, Inc. | -7.51 Million USD | 5577.045% |
Arcadia Biosciences, Inc. | -13.93 Million USD | 3053.645% |
Yield10 Bioscience, Inc. | -14.12 Million USD | 3014.129% |